Cue Biopharma Inc. (CUE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.29
0.07 (5.74%)
At close: Jan 15, 2025, 11:38 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -50.73M | -53.01M | -44.16M | -44.78M | -36.70M | -38.98M | -23.23M | -7.66M | -1.93M |
Depreciation & Amortization | 3.44M | 1.81M | -1.78M | 1.06M | 5.17M | 760.01K | 419.57K | 202.09K | 44.81K |
Stock-Based Compensation | 8.18M | 9.50M | 11.52M | 10.48M | 6.52M | 7.17M | 2.78M | 889.56K | n/a |
Other Working Capital | -63.00K | -2.81M | -7.97M | -3.70M | 928.59K | 3.83M | 2.35M | 532.32K | -31.01K |
Other Non-Cash Items | 90.00K | -453.78K | -26.13K | -563.23K | -4.28M | 345.10K | 4.93M | 65.91K | 79.55K |
Deferred Income Tax | n/a | n/a | n/a | 83.69K | -18.19K | 79.86K | 10.68K | n/a | n/a |
Change in Working Capital | -934.00K | 356.27K | -4.39M | 1.23M | -1.49M | 4.21M | 2.91M | 532.32K | 146.80K |
Operating Cash Flow | -39.96M | -41.81M | -38.84M | -32.49M | -30.80M | -26.41M | -12.19M | -5.97M | -1.66M |
Capital Expenditures | n/a | -170.75K | -913.04K | -595.26K | -46.35K | -1.85M | -1.20M | -515.98K | -754.29K |
Acquisitions | n/a | 6.21K | 4.58K | 83.69K | 127.50K | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -29.45M | -4.58K | -9.95M | -15.13M | -39.50M | n/a | n/a | n/a |
Sales Maturities Of Investments | 25.00M | 5.00M | 10.00M | 15.00M | 18.50M | 21.00M | n/a | n/a | n/a |
Other Investing Acitivies | 2.00K | -24.44M | 21.55K | -83.69K | 3.49M | -18.50M | -35 | -33 | -50.00K |
Investing Cash Flow | 25.00M | -24.61M | 9.11M | 4.46M | 3.45M | -20.35M | -1.20M | -516.01K | -804.29K |
Debt Repayment | -2.00M | 10.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -271.05K | -91.03K | n/a | -4.16M | -1.41M | -1.14M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 473.00K | 4.36M | 1.85M | 1.93M | 1.79M | 12.50K | 9.01K | n/a | 1K |
Financial Cash Flow | 11.86M | 53.66M | 19.23M | 58.61M | 50.79M | 4.18M | 62.00M | 15.01M | 8.87M |
Net Cash Flow | -3.10M | -12.76M | -10.50M | 30.58M | 23.44M | -42.58M | 48.61M | 8.52M | 6.41M |
Free Cash Flow | -39.96M | -41.98M | -39.75M | -33.09M | -30.84M | -28.27M | -13.40M | -6.48M | -2.41M |